Raia Drogasil S.A.
RADLY
$4.66
$0.071.48%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.83% | 2.83% | -6.59% | -4.29% | 1.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.83% | 2.83% | -6.59% | -4.29% | 1.28% |
| Cost of Revenue | 15.33% | 3.88% | -5.89% | -3.64% | 1.44% |
| Gross Profit | 13.65% | 0.40% | -8.30% | -5.80% | 0.89% |
| SG&A Expenses | 12.76% | 0.63% | -4.46% | -5.63% | -2.38% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -88.52% | -5,434.94% | 140.85% | -- |
| Total Operating Expenses | 14.69% | 2.98% | -5.92% | -2.94% | 1.02% |
| Operating Income | 16.88% | 0.66% | -17.62% | -24.79% | 5.12% |
| Income Before Tax | 25.77% | -11.57% | -39.48% | -20.00% | 28.49% |
| Income Tax Expenses | -17.07% | -82.10% | -65.57% | -442.88% | 165.86% |
| Earnings from Continuing Operations | 38.63% | 7.15% | -27.78% | 6.00% | 11.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -91.34% | -302.91% | 82.86% | 100.59% | 19.08% |
| Net Income | 37.98% | 5.31% | -26.17% | 13.04% | 11.76% |
| EBIT | 16.88% | 0.66% | -17.62% | -24.79% | 5.12% |
| EBITDA | 14.61% | 2.15% | -14.98% | -20.61% | 2.95% |
| EPS Basic | 38.25% | 83.64% | -26.09% | 17.61% | 14.38% |
| Normalized Basic EPS | 7.81% | 49.41% | -28.02% | -26.34% | 19.03% |
| EPS Diluted | 37.91% | 82.71% | -25.55% | 17.61% | 13.75% |
| Normalized Diluted EPS | 7.09% | 48.24% | -27.32% | -26.34% | 18.58% |
| Average Basic Shares Outstanding | -0.14% | -42.57% | -0.15% | -3.84% | -2.33% |
| Average Diluted Shares Outstanding | 0.09% | -42.26% | -0.80% | -3.84% | -1.74% |
| Dividend Per Share | -34.63% | -- | -- | -- | -- |
| Payout Ratio | -0.95% | 0.13% | -0.40% | -0.26% | 1.89% |